ISSN 0303-5212
 
2023, Vol: 48, Issue: 2
48 / 2Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Author certificate
Bank Reciept

Original Research 
RMJ. 2023; 48(3): 565-567


Elevated lactate dehydrogenase (LDH) and C- reactive protein (CRP) level as a risk factor for critical COVID-19

Wafaa Hazim Salih.

Abstract
Objective: To identify correlation of elevated LDH & CRP levels with the outcomes of COVID-19.
Methodology: The cross-sectional retrospective study consisted of 200 COVID-19 patients who presented at a private clinical in Baghdad, Iraq. It was carried out from February 2021 to February 2022. Data included age, gender and clinical presentation. Blood samples were taken for high sensitivity CRP and LDH in the serum.
Results: Out of 200 patients, 50 were critical and 150 severe according to clinical features. LDH and CRP showed a significant increase (p=0.000) in critical patients. This group involved admission to the respiratory intensive care unit requiring mechanical ventilation than in patients with severe COVID-19 (760.5±6.3 vs. 290.3±4.1 and 44.9±7.6 vs. 25.4±2.3, respectively)
Conclusions: LDH and CRP in critical COVID-19 patients may be considered as a risk factor for predicting the bad progression of the disease.

Key words: LDH, COVID, severity, CRP, critical.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Wafaa Hazim Salih
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Wafaa Hazim Salih. Elevated lactate dehydrogenase (LDH) and C- reactive protein (CRP) level as a risk factor for critical COVID-19 . RMJ. 2023; 48(3): 565-567.

Web Style

Wafaa Hazim Salih. Elevated lactate dehydrogenase (LDH) and C- reactive protein (CRP) level as a risk factor for critical COVID-19 . https://www.rmj.org.pk/?mno=168872 [Access: September 09, 2023].

AMA (American Medical Association) Style

Wafaa Hazim Salih. Elevated lactate dehydrogenase (LDH) and C- reactive protein (CRP) level as a risk factor for critical COVID-19 . RMJ. 2023; 48(3): 565-567.


Vancouver/ICMJE Style

Wafaa Hazim Salih. Elevated lactate dehydrogenase (LDH) and C- reactive protein (CRP) level as a risk factor for critical COVID-19 . RMJ. (2023), [cited September 09, 2023]; 48(3): 565-567.


Harvard Style

Wafaa Hazim Salih (2023) Elevated lactate dehydrogenase (LDH) and C- reactive protein (CRP) level as a risk factor for critical COVID-19 . RMJ, 48 (3), 565-567.


Turabian Style

Wafaa Hazim Salih. 2023. Elevated lactate dehydrogenase (LDH) and C- reactive protein (CRP) level as a risk factor for critical COVID-19 . Rawal Medical Journal, 48 (3), 565-567.


Chicago Style

Wafaa Hazim Salih. "Elevated lactate dehydrogenase (LDH) and C- reactive protein (CRP) level as a risk factor for critical COVID-19 ." Rawal Medical Journal 48 (2023), 565-567.


MLA (The Modern Language Association) Style

Wafaa Hazim Salih. "Elevated lactate dehydrogenase (LDH) and C- reactive protein (CRP) level as a risk factor for critical COVID-19 ." Rawal Medical Journal 48.3 (2023), 565-567. Print.


APA (American Psychological Association) Style

Wafaa Hazim Salih (2023) Elevated lactate dehydrogenase (LDH) and C- reactive protein (CRP) level as a risk factor for critical COVID-19 . Rawal Medical Journal, 48 (3), 565-567.


Author LoginReviewer LoginEditorial PoliciesConflict of Interest PolicyPlagiarism PolicyAdvertising Policy

About Rawal Medical Journal

Publication, subscription and Editorial office PMA House G/220-B Liaquat Road, Rawalpindi. Phone: 051-555-9812, Fax: 051-553-7088 Email: drnkhokhar@ya ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information